Sysmex
Sustainability
Report2015
Digest Version

Contents
1

Contents/Editorial Policy

2

Corporate Philosophy

3

Message from the Chairman and CEO

5

Sysmex at a Glance

7
Highlight

19Highlight

2

7P

Expanding our Lineup of Immunoassay
Analyzers and Reagents That Contributeto the Early Detection and Treatment of
Infectious Diseases, Cancer andOther Diseases

9

Opening of i-Square, a Core Instrument
Factory Focused on Delivering
High-Quality Products in a Stable MannerP

11Highlight

3
13

Employee Volunteers Conduct Fund-RaisingCampaign to Help Fight Cancer

Global CSR Activity Highlights
13 Japan
15 Americas
16 EMEA*

11

17 China
18 Asia PacificP* Europe, the Middle East and Africa

19

Sysmex’s CSR Activities

21

Corporate Information/Information Available on the Website

Editorial Policy
Sysmex publishes the annual “Sysmex Sustainability Report”
in the hopes of communicating its approaches and activities
concerning corporate social responsibility (CSR) to stakeholders
and facilitating dialog with them. This report is available as a fullversion and in digest form, as well as on the Company’s website.

Organizations covered

Informational content of each media

Primarily fiscal 2014 (from April 1, 2014 to March 31, 2015). Some activities
conducted outside this period are also included.

• Sysmex Sustainability Report 2015 (Full Version), CSR Site:
Comprehensive information
Provides exhaustive coverage of the Company’s CSR initiatives• Sysmex Sustainability Report 2015 (Digest Version):
Excerpts of key information only
Contains excerpted content the Company wishes particularly tocommunicate to stakeholders

Inquiries about this report
CSR Promotion Department, Sysmex Corporation
1-5-1, Wakinohama-Kaigandori, Chuo-ku, Kobe, Hyogo, 651-0073, Japan
Tel +81-78-265-0500, Fax +81-78-265-0524

1

Sysmex Sustainability Report 2015

Sysmex Group (Sysmex Corporation and its subsidiaries both in Japan andabroad). In this report, “Sysmex” refers to the Sysmex Group as a whole.
“Sysmex Corporation” refers to the Company on a stand-alone basis.

Period covered

Date of publication
August 2015
Previous version: August 2014

Guidelines referenced• The Global Reporting Initiative (GRI)'s Sustainability Reporting
Guidelines, Edition 3.1• The Japanese Ministry of the Environment's Environmental Reporting
Guidelines (2012 ed.)

Corporate Philosophy

Core Behaviors
To our Customers
We deliver reassurance to our customers, through unmatched quality, advanced technologies, superior support,
and actions that consistently reflect the viewpoint of our customers. We constantly look out for our customers’true needs, and seek to generate new solutions to satisfy those needs.

To our Employees
We honor diversity, respect the individuality of each employee, and provide them with a workplace where
they can realize their full potential. We value the spirit of independence and challenge, provide employeeswith opportunities for self-fulfillment and growth, and reward them for their accomplishments.

To our Business Partners
We deliver commitment to our client companies through broad-ranging partnerships. We strive to be a company
that can grow in step with our trade partners, through respect and mutual trust.

To our Shareholders
Our shareholders can rest assured that we will continue to improve the soundness and transparency of ourmanagement policies, while promoting information disclosure and close communications. We commit ourselves
to a consistent yet innovative style of management, in order to achieve sustainable growth and increased
shareholder value.

To Society
We carry out our business in strict compliance with laws and regulations, as well as in adherence to high ethicalstandards. As a responsible member of society, we play an active role in resolving environmental issues andother problems that impact our society today.

Sysmex Sustainability Report 20152

Message from the Chairman and CEO

We address the shared desire of all people to remain healthy
by providing products and services backed by leading-edge
technologies and building trust and confidence.

Contributing to the Advancement of Healthcare
through Testing
In line with our mission of “shaping the advancement ofhealthcare,” which is defined in the “Sysmex Way,” thecorporate philosophy for the Sysmex Group, Sysmex works
to contribute to the development of healthcare and thehealthy lives of people. Since our founding in 1968, we havecreated a wide spectrum of products and services in thein-vitro diagnostics field based on advanced technologies,
and the Group’s products are used in more than 190 countries
around the world.
In recent years, the environment surrounding thehealthcare business has changed dramatically. In advanced
countries, new needs are emerging as populations age andattention focuses on individually optimized healthcare(personalized medicine). Meanwhile, emerging markets—
including China and countries in Southeast Asia and Central
and South America—are working to expand their healthcare
infrastructures and offer more sophisticated healthcare inline with their economic development.
In this environment, testing is playing an increasingly
important role in illness prevention, early detection and thedetermination of treatment methods. We aim to swiftly
address these changes in the environment and respond topeople’s desire to remain healthy by meeting increasingly
diverse and advanced testing needs.
In fiscal 2014, we launched the HISCL-800, a new productin the HISCL-Series of automated immunoassay analyzers
that aids in the diagnosis of infectious diseases, cancers, heartdiseases and autoimmune diseases and in monitoring theircourses of treatment. This product inherits such series
characteristics as minute samples, a high degree of sensitivity
and fast measurement, and is compact, being approximately
60% the width of existing models. We also introduced the
XN-L-Series, a compact automated hematology analyzer.
Aimed primarily to meet demand at small and medium-sizedfacilities in advanced markets and expected growth in3

Sysmex Sustainability Report 2015

emerging markets, with these products we expect to provide
advanced testing in numerous regions and circumstances.

Building Trust and Confidence among
Stakeholders
In keeping with its corporate philosophy, Sysmex prioritizes
the building of trust and confidence among its stakeholders.
In fiscal 2014, we responded to growing global demand
for testing by reorganizing our instrument manufacturing
structure, creating a system to ensure the stable delivery of
products of even higher quality. We opened the doors ofi-Square, a new factory in the city of Kakogawa, Hyogo
Prefecture, and expanded the factories at two Group
companies in Japan. These moves will approximately triple
our future supply capacity at our four factories, including
Kakogawa Factory. We also set up a logistics center within
i-Square to directly link our manufacturing and distributionfunctions. At the same time, we revised our product packaging
materials and promoted such reforms as increasing loading
ratios. In addition to making logistics more efficient, thesemoves are helping to reduce our CO2 footprint. Overseas,
we augmented production capacities at our reagent
factories in Singapore and Germany. As well as ensuringhigh levels of quality and production efficiency, we strove
to make these factories even more comfortable places for
employees to work.
Besides its business-related initiatives, Sysmex also
undertook a variety of social contribution activities. For
example, because as a healthcare company we believe incontributing to a healthy society through sports, we havesupported the Kobe Marathon since its inception. We werea special sponsor of the fourth Kobe Marathon, which washeld in November 2014, and our volunteers supported event
operations in such ways as providing water to runners.
Overseas, we conduct a host of social contribution
activities tailored to the characteristics of individual regions.
To help stamp out cancer, one of the world’s most deadlydiseases, in fiscal 2014 we launched the Sysmex Against
Cancer campaign in the EMEA* region. Employee volunteers
from different locations joined together in planning andconducting a variety of fund-raising events, with proceeds
donated to the World Cancer Research Fund.
* Europe, the Middle East and Africa

Aiming to Make Further Progress with a New
Mid-Term Management Plan
We have recently formulated a new Group mid-term
management plan to guide Sysmex through fiscal 2017.
In addition to developing high-value-added productsthat anticipate customers’ needs and rolling out a global
business strategy, this plan calls for the Company toaugment management soundness and transparency byrevising its internal control system. These measures areintended to enhance our sustainable corporate value.
We will also reinforce interactive communication withdiverse stakeholders.
When formulating our mid-term management plan,
we also revised our mid-term CSR plan. This plan is basedon the 10 principles of the United Nations Global Compact,which the Company joined in 2011, and ISO 26000. The
plan calls for further globalization of our businesses andre-establishes targets for future activities based on theincreasingly diverse and sophisticated demands andexpectations of our stakeholders.
Sysmex aims to continue achieving sustainable growth
going forward and strives to earn the trust of all our
stakeholders. As we undertake these endeavors, I ask for yourfurther understanding and support going forward.

July 2015
Hisashi Ietsugu
Chairman and CEO

Sysmex Sustainability Report 20154

Sysmex at a Glance

Supporting the Lives and Health of People Worldwide by
Providing the Instruments, Reagents and Software used in
In-Vitro Diagnostics*
Addressing
the Problems
Faced byPatients and
Healthcare
Professionals
Reducing the Burden on Patients

Helping Physicians Diagnose Swiftly

Reducing the Burden for Laboratory
Technologists and Enhancing Efficiency

Sysmex products
are in use
near you.

3

1

1

3
2
1

5

Sysmex Sustainability Report 20152

* In-vitro diagnostics are a type of laboratory testing. Whereas In-vitro diagnostics
involves tests conducted directly on patients’ bodies, such as electrocardiograms
and ultrasound, with In-vitro diagnosis tests are performed on samples (specimens)
taken from a patient’s body, such as blood and urine, analyzing the shape and numberof constituents and cells contained in these samples.

Integrated
Systemfrom R&D to
After-Sales
Support
R&D

Production

Sales

After-sales Support

1 Hospitals

Hematology Field

Urinalysis Field

Hematology, which involves measuring
and analyzing the number, type andsize of red, white and other blood
cells, allows the presence of anemia or
infectious disease to be determined.

Urinalysis entails testing forthe presence of sugar, protein
or blood in the urine, aiding in
the diagnosis of a variety of
diseases.

XN-Series XN-2000
Automated Hematology Analyzer

UF-1000 i
Automated Urine Particle Analyzer

Hemostasis Field

Life Science Field

Hemostasis supports the diagnosis andtreatment monitoring of the mechanismthat prevents blood from clotting (as inhemophilia) or disorders resulting fromthrombi (as with cerebral infarction).

Leading-edge technologies are used to analyze genes and proteins,performing molecular diagnostics related to diseases, centeringon cancer.

CS-5100
Automated Blood Coagulation Analyzer

Immunochemistry Field

The One-Step Nucleic Acid Amplification (OSNA) method that Sysmex has
developed can be used to detect target genes in lymph nodes quickly, easily
and with a high degree of precision. This technology is currently eligible for
insurance coverage in testing for breast cancer, colorectal cancer and stomach
cancer. The technology is also a focus of R&D attention in realizing personalized
medicine, including for studying the effectiveness of anti-cancer agents.

Immunochemistry is performed on blood
serum, the supernatant fluid isolated
after blood separates, to test for thepresence of the hepatitis virus, measurethyroid hormone and check for cancer.
HISCL-5000
Automated Immunoassay System

2 Animal Hospitals
Our products for animals help manage the healthof dogs and cats, as well as aquarium dolphinsand zoo animals.
pocH-100iV Diff
Automated Hematology Analyzer

RD-100 i
Gene Amplification Detector

3 Sports Training Facilities
Our health monitoring analyzer measuresures
pling andhemoglobin levels without blood sampling
ondition.
is used as a tool for monitoring athletic condition.
ASTRIM FIT
Health Monitoring Analyzer

Sysmex Sustainability Report 20156

Highlight 1
Expanding our Lineup of Immunoassay Analyzers andReagents That Contribute to the Early Detection andTreatment of Infectious Diseases, Cancer and Other Diseases
Launch of a Compact and High-Performance Immunoassay Analyzer to Meet
1 Diverse
Needs around the WorldAs a way of measuring proteins and other substances inthe blood, immunochemistry testing has a wide range ofapplications, from diagnosis of infectious diseases, cancers,
heart diseases and autoimmune diseases to monitoring thecourse of treatment. As such, immunochemistry testing
plays an essential role in the early detection of diseases
and determination of therapeutic effects. To meet a variety
of testing needs related to immunochemistry testing, Sysmex
has expanded its lineup of HISCL-Series automatedimmunoassay analyzers.
In September 2014, we launched the HISCL-800, which
carries forward such HISCL-Series characteristics as minutesamples, a high degree of sensitivity and fast measurement(requiring only 17 minutes). At the same time, the HISCL-800

is space-saving, with a footprint approximately 60% thewidth of the HISCL-5000. This instrument, which offers
high functionality and performance, as well as being
space-saving, is expected to contribute to high-value-added
testing in emerging markets such as China and other Asian
countries that are slated for future growth. Contributing totesting efficiency, the interface employs a large, 21-inchcolor touch-panel display and uses large icons to ensure ahigh level of visibility and operability.
This model works with the Sysmex Network
Communications Systems (SNCS)* to determine the statusof a customer’s instrument and pre-empt malfunctions.
This functionality helps in configuring a testing environmentthat is convenient and instills customer confidence.
* A separate agreement is needed to use this service.

Diseases for which immunochemistry tests contributeto diagnosis and monitoring of courses of treatment

Infectious
diseases

CancerHeart
diseaseHISCL-800
Automated Immunoassay System

Autoimmune
diseases

Principal characteristics of HISCL-Series fully automatedimmunoassay analyzers

Rapid
measurement
requiring only

17
minutes

Minutesamples(10–30μL)

Highsensitivity• Increased testing efficiency• Highly reliable testing results• Reduced burden on patients
7

Sysmex Sustainability Report 2015

Instrument width
approximately

60of the existing model, the HISCL-5000

Space-saving%

C

What is viral hepatitis ?

One of Japan’s mostprominent infectious diseases

B

Affectingsome3

millionpeopleMay lead to liver cirrhosis andhepatocellular carcinoma
Characteristics of the new reagent, HISCL M2BPGi

Reduces the burden on patientsand leads to more efficient testing
Quickly determines liver fibrosis progression
with only a blood sample
Asymptomatic
virus carriers,
acute hepatitis

Chronic
hepatitisLivercirrhosis

Hepatocellular
carcinoma

Degree of liver fibrosis progression≒ Potential development into liver cirrhosis,
hepatocellular carcinoma

New Reagent That Helps to2 AReduce
the Burden on Patients
When Diagnosing Hepatic
Virus-Induced Diseases
In January 2015, Sysmex’s new reagent for the HISCL-Series,
the HISCL M2BPGi Assay Kit, received approval for healthinsurance coverage in Japan. This reagent is able todetermine in a short period of time the degree of liver
fibrosis progression (hepatic fibrosis).
Left untreated, viral hepatitis, one of Japan’s leading
infectious diseases, can progress from chronic hepatitis andliver cirrhosis to hepatocellular carcinoma. To treat thisdisease, determining the degree of hepatic fibrosis due tothe hepatitis virus is key. At present, the typical testingprocess involves living tissue diagnosis, or taking a biopsyof the liver tissue. This method requires hospitalization,
placing a substantial burden on the patient on both thephysical and economic fronts.
Using the HISCL M2BPGi Assay Kit and HISCL-Series
immunoassay analyzers (HISCL-5000/2000i /800) allows
the degree of hepatic fibrosis progression to be quickly
measured with only a blood sample. This method is expected
to reduce the burden on the patient and lead to more
efficient testing.

to the Automation of Testing for Atopic Dermatitis and Greatly
3 Contributing
Reducing the Time Required for Diagnosis
In April 2014, Sysmex began offering the HISCL TARC Assay
Kit for diagnosing atopic dermatitis.
An objective approach to diagnosing atopic dermatitis
involves measuring the amount of a substance called TARC*
produced in the blood, thereby evaluating the severity ofthe disease and measuring therapeutic effects. In the past,these tests have been performed manually, typically requiring
more than three hours. By using a HISCL-Series instrument
and the HISCL TARC Assay Kit, this testing can be automated,
reducing testing time to only around 17 minutes.
By further expanding its lineup of immunoassay analyzers
and reagents, Sysmex aims to contribute to enhancing thequality of testing and reducing the burden on patients.
* An abbreviation for thymus and activation-regulated chemokine, a substancethat causes cells in the blood to migrate to the skin, resulting in allergic
inflammation.

CustomerComment

Time required to measure
TARC production volume

Substantiallyreduces testing time

1/11

To approximatelyof manual method(From approximately 3 hours,
15 minutes to around 17 minutes)

Impressions from Using the HISCL-800: “Easy to Use and Hassle Free”
We decided to introduce the HISCL-800 because it was perfectly sized for our laboratory and because of the quick,polite and reliable responses of Sysmex’s sales, support and scientific personnel. In addition to the instrument
itself being compact, all the necessary reagents can be stored within the instrument, which makes the lab neatand tidy. The touch-screen monitor makes the instrument easy to use and it requires hardly any maintenance.
From my perspective, the HISCL-800 is easy to use and hassle free.

Momoyo Sakai, Chief of Clinical Laboratory, Healthcare Corporation TOSEIKAI, Suwa Maternity Clinic

Sysmex Sustainability Report 20158

Highlight 2
Opening of i-Square, a Core Instrument Factory Focusedon Delivering High-Quality Products in a Stable Manner

the Group’s Overall Production System to Meet Growing Demand
1 Rearranging
for Testing
Sysmex leverages its advanced “made in Japan” technologicalcapabilities to manufacture IVD instruments that are shipped
to customers in more than 190 countries.
Recent years have seen increasing healthcare and testingneeds in China and other emerging markets, as well as
advanced countries, and demand for our instruments hasgrown sharply. In response to these conditions, in June2014 Sysmex established i-Square, a new factory in the cityof Kakogawa, Hyogo Prefecture, with a site area of 30,000
square meters. We took the establishment of i-Square asan opportunity to revise the Group’s instrument productiona System to
2 Configuring
Manufacture and Supply

i-Square Features Manufacturing

Uncompromising
pursuit of highquality

ICT
Utilization of

Screen from a 3D moving manual(Information andCommunications
Technology)

in manufacturing

i-Square Features Logistics

Achieves highly efficient operations

Directly linking the
manufacturing andlogistics functions

9

Sysmex Sustainability Report 2015

system. We reorganized our structure to manufacturecompact models at the Kakogawa Factory, as well as theSysmex Medica and Sysmex RA factories. Sysmex Medica(Himeji, Hyogo Prefecture) specializes in the assembly ofunits for high-end models, and Sysmex RA (Shiojiri, Nagano
Prefecture) focuses on the manufacture of peripheral
equipment for IVD instruments.
These revisions will allow the Sysmex Group to triple
its instrument manufacturing capacity, thereby meeting
growing global needs.

High-Quality Products Efficiently
The manufacturing area at i-Square is designed around theconcept of manufacturing high-quality products through a
combination of people and technology, promoting the use of
ICT in “digital manufacturing.” The Smart Pro manufacturing
support system directs workers and testing personnel,
accumulates working and testing results, and creates
manufacturing and testing records. Linking with Smart Pro
are 3D “moving manuals” that use displays to demonstrate
operations to workers using three-dimensional animations,
resulting in high-quality, highly efficient manufacturing.
i-Square also serves a central function in managing
instrument logistics. Whereas in the past instruments
manufactured at our factories were stored in external
warehouses, i-Square houses an internal logistics center
that directly links the manufacturing and logistics functions.
This system allows inventories to be managed as products
are manufactured. By significantly improving operational
efficiency, the new arrangement enables us to provide
instruments to the market more swiftly than in the past.

Overview of Instrument Manufacturing Locations
Sysmex,i-SquareSysmexKakogawa Factory

Sysmex Medica

Sysmex RA

Location

Kakogawa,
Hyogo Prefecture

Kakogawa,
Hyogo Prefecture

Himeji,
Hyogo Prefecture

Shiojiri,
Nagano Prefecture

Site area

Approx. 30,000m2

Approx. 12,000m2

Approx. 7,300m2

Approx. 6,100m2

Floor space

Approx. 20,000m2

Approx. 9,800m2

Approx. 4,400m2

Approx. 6,000m2

Main products

High-end models

Compact models

High-end units

Peripheral equipment

Eventually Approximately

Tripling
the Group’s
Overall Instrument
Manufacturing Capacity

Responding to Growing Global Needs for Testing
I-Squarefor the Environment
3 Considerationand the Local Community
i-Square is designed to minimize environmental impact.
LED lighting and solar power modules have been introduced
to conserve energy and lower CO2 emissions. Furthermore,
the factory is surrounded by a variety of greenery, with trees,
water and light in abundance. A mound of earth near theentrance of i-Square serves as an important symbol for thefactory. Made with excess soil from construction that wasleft in place rather than being carted away, the hillock
serves as a reminder of this reduced environmental impact.
The industrial complex where the factory is situatedadjoins a housing area, and numerous schools are locatednearby. Sysmex has set aside a portion of its site as anaccess road for students commuting to school, and hasreceived a certificate of appreciation from the city of
Kakogawa for its contribution to children’s safety during
their commute to school.
Going forward, Sysmex plans to continue its efforts toreinforce its manufacturing and logistics structures to takethe environment into consideration while ensuring thestable provision of high-quality products around the world.

Employee
Comment

Using Natural Energy
at i-Square

Reducing
Environmental Impact
Generating110

kWh throughSolar Power(Accounting for 10% of all power used at i-Square)In fiscal 2014, greenhouse gas
emissions at Sysmex’s factories
and primary business offices were
down 9% year on year per unit ofsales, although the absolute
number increased due to theestablishment of i-Squareand other factors.

An Easy Factory for Employees to Work in, and Convenient for Hosting Tour Guests
i-Square is a marriage between natural beauty and functionality. The facility is “people-friendly” in that in addition
to being a comfortable place to work, it is convenient for hosting tour guests and people in the surrounding
community, and features an abundance of trees, water and light. The manufacturing area is characterized by apillarless, astylar configuration. This arrangement allows layouts to be flexibly adjusted as demands dictate.

Wataru Kaneshika, Production Control Department, Instrument Production Division, Sysmex Corporation

Sysmex Sustainability Report 201510

Highlight 3
Employee Volunteers Conduct Fund-Raising Campaign
to Help Fight Cancer

1 “Sysmex Against Cancer” Campaign
Cancer is the world’s deadliest disease. Given that the
number of deaths from cancer is forecast to continue
increasing, in addition to improving treatment methods
there is a growing need to address the illness throughprevention and early detection. Sysmex manufactures andsells products that assist in the early detection of cancer.
We also make donations*1 to the American Cancer Society
and other organizations that work to prevent and conduct

The World’s
Deadliest Disease

13.0

millionThroughout the world, an estimated
14.0 million people fell ill with cancer
in 2012, and around 8.2 million
people died from the disease. By
2030, these figures are forecast to
climb to 22.0 million and 13.0
million, respectively.

8.2

millionSource: World Cancer Report
2014, International Agency for
Research on Cancer

2012(Estimate)*1 For details, please see the section on page 15 of this report, entitled “Making
Ongoing Contributions to Organizations That Support Cancer Prevention
and Research”*2 Europe, the Middle East and Africa

in a Number of Fund-Raising
2 Leading
Activities in the EMEA*1 Region

World Cancer Status

Deaths from
Cancerresearch on cancer. In these ways, the Company is working
proactively to contribute to society by fighting cancer.
In fiscal 2014, employee volunteers at Group companies
in the EMEA*2 region launched the cancer-fighting campaign“Sysmex Against Cancer.”

As part of the Sysmex Against Cancer campaign, a dedicatedwebsite has been set up to publicize the host of events
employees have planned and to solicit donations. These
funds are donated to the World Cancer Research Fund*2,
which raises awareness of cancer prevention andsupports research.
These activities span the entire EMEA region, from
Russia to South Africa, from the United Kingdom to theMiddle East. Events are diverse, including sales of food,precious stones and caps, holding auctions and hosting
lectures by specialists. As of April 2015, a total of 162 events
had been held.
*1 Europe, the Middle East and Africa*2 The World Cancer Research Fund is a non-profit organization headquarteredin London, England. The fund promotes awareness of cancer-prevention
measures and provides funding for scientific research on the relationshipbetween cancer and such factors as food, exercise and obesity.

2030(Forecast)

Employee
Comment

A Major Project Combining the Efforts of Employees in 15 Countries
Many people in our lives are affected by cancer in one way or another. Sysmex is no exception. Sadly, two of
our beloved colleagues passed away from cancer on the same day. As people involved in healthcare, thisevent led us to wonder what we might be able to do, and we launched the “Sysmex Against Cancer” campaign.
On April 12, 2015, employees in 15 countries combined their energies to take part in a major project.

Jos van de Ven, IVD Division, Sysmex Nederland

11

Sysmex Sustainability Report 2015

Contribution Activities through3 Conducting
the NN Marathon Rotterdam
On April 12, 2015, one of the largest projects so far in theSysmex Against Cancer campaign was held to raise funds
through the 2015 NN Marathon Rotterdam. Each year,
more than 20,000 runners take part in this event, which is
the largest marathon in the Netherlands. Some 96 Sysmex
employees—92 from Europe, one from the Middle East andthree from Africa—ran in the marathon. When participants
applied to take part in the marathon, they agreed to try andraise funds for the World Cancer Research Fund.
As a result of these activities, by the end of April 2015
the Sysmex Against Cancer campaign had raised a total of€241,733 (approximately ¥31.5 million*) which it contributed
to the World Cancer Research Fund. Through this campaign,
we plan to continue contributing to the fight against cancer.
Going forward, in tandem with employees and local
communities Sysmex will continue working proactively onsocial contribution activities that address the various
problems society faces.

Amassing Donations throughSysmex Against Cancer

Contributing to the World
Cancer Research Fund

€241,733(Approximately ¥31.5 million)

Contribution presentation
ceremony*Calculated at €1.00 = ¥130.32, the exchange rate on March 31, 2015

Sysmex employees who participated in the NN Marathon Rotterdam

Overview of the Sysmex Against Cancer
Campaign

162
Fund-Raising
Activities,

IncludingParticipation in the NN
Marathon Rotterdam

Taking part in a host of fund-raising activities

Sysmex Sustainability Report 201512

Global CSR Activity Highlights

Japan
Space-saving
Approximately

In the Hematology Field,
Launch of Compact Models
in the XN Family

70%
the width ofcurrent products*

In December 2014, Sysmex launched the XN-L-Series (XN-550, XN-450
and XN-350) of automated multiparameter hematology analyzers.
These compact models are part of the Company’s flagship model inthe hematology field, the XN-Series. The width of the systemcomprising the new series and its data processing unit have been
reduced to about 70% that of current compact models*. In addition,
the new series offers high levels of performance and operability, andis aimed at small- and medium-sized healthcare facilities, as well as
emergency laboratories at large-scale institutions.
* Compared with the XN-350 and XS-800i (main instrument plus data processing unit)

XN-550

XN-450

XN-350Establishment of a New Development Basefor Companion Diagnostic Drugs

Technical Training at the Monozukuri
Training CenterIn the area of cancer treatment, demand is growing to realize andpromote personalized medicine, which is optimized for individual
patients. In line with this trend, expectations are growing forcompanion diagnostic drugs, which are used to predict theefficacy and side effects of drugs before using them as treatment.
To accelerate R&D on companion diagnostic drugs, in December
2014 Sysmex established a new base on Kobe Port Island todevelop these drugs and provide lab assay services.

Sysmex has established the Monozukuri Training Center at its
Kakogawa Factory to provide technical training for new
employees, as well as part-time and temporary employees.
This center was expanded in fiscal 2014 as part of the renovation
work conducted at Kakogawa Factory, increasing the numberof training topics it handles. We have also shared this center’s
educational know-how with other factories to augment on-site
human resource development.
Total Number of People Undergoing Training at the
Monozukuri Training Center

1,000

Base for companion
diagnostic drug
development and lab
assay services

13

Sysmex Sustainability Report 2015

238

302

2010

2011

669

709

2012

2013 2014(FY)

Sponsorship of the Kobe Marathon 2014
Sysmex Corporation has been a special sponsor of this event
since its inception. With a theme of “Thanks and Friendship,”
the Kobe Marathon is meant to express the gratitude of thepeople of the Kobe area to everyone who assisted in thereconstruction of the region following the Great Hanshin-Awaji
Earthquake. For the fourth marathon, held in November 2014,
Sysmex supplied bib numbers to runners and fielded volunteers
who provided operational support. Sysmex also exhibited at the
Kobe Marathon
EXPO.

Introduction of a Social Contribution
Point Program to Encourage Employee
Volunteer Activities
Sysmex introduced a Social Contribution Point Program in April
2014. Under this program, employees earn individual points
for taking part in social contribution activities, as well as forparticipating in social contribution events sponsored by theCompany. The Company makes a donation corresponding to thenumber of points accumulated at the end of each fiscal year.
Under this program, in fiscal 2014 Sysmex donated ¥970,000
worth of measles vaccines, antimalarial mosquito nets andemergency medical kits to developing countries via UNICEF.

The result of the Social Contribution Programin Fiscal 2014
Approximately 28 % of Group employees in Japan participated,a total of 837 people.
A total of ¥972,200 was donated, corresponding
to 9,722 points.
• Measles vaccines: 10,600 doses• Emergency medical kits: 78• Antimalarial mosquito nets: 770
Volunteers providing water(136 Group employees and their family members participated)

Average training hours
per employee (fiscal 2014)

Approximately

28

hours

Average training expenditure
per employee (fiscal 2014)

Approximately¥160,000

Human Resource
Development Basedon Four Concepts
Based on its four concepts for human resource development, Sysmex
Corporation operates a training system offering selective, rank-basedand elective training that seeks to nurture personnel in a planned andgradual manner. In fiscal 2014, on average each employee underwent
28.2 hours of training, and average per-employee expenditure amounted
to ¥157,789*. Furthermore, in April 2015 Sysmex opened the Global
Communication Center in Okuike, Ashiya, Hyogo Prefecture. This new
facility aims to serve as a gathering place for people of diverse culturesand values, encouraging communication in surroundings that provide
a break from everyday routines and foster broader networks.
* This figure indicates training provided by the Human Resources Department and excludes certain
types of training, such as self-development and training related to specialized work for divisions.

Four Concepts of Human
Resource Development

1

Link training, evaluation andwork (show results)

2

Promote globalization of
the Sysmex Group3

Invest in ongoing humanresource development

4

Be a company that cultivates
human resources andpersonal growth

New employee training

Global Communication Center (theater room)

Sysmex Sustainability Report 201514

Global CSR Activity Highlights

Americas
Providing Extensive
Support to Boost
Customer Satisfaction
Sysmex America, the regional headquarters for the Americas, has striven
over many years to provide customer support to ensure that instruments
operate soundly at customer sites. As one indicator of the successof such support, the company has received the top ranking among
manufacturers of hematology analyzers in an IMV ServiceTrak survey(sponsored by IMV) of customer satisfaction for 15 consecutive years.
Sysmex America has also won the Ace-Award (sponsored by Confirmit)
for four consecutive years for excellent corporate results on customer
feedback. Furthermore, the company scored well in an independent
survey conducted in 2014, receiving an overall rating of 9.1 out of a
10.0 scale for customer satisfaction.

Customer
Satisfaction Survey
Ranks Sysmex America

No.1

for 15 ConsecutiveYears

IMV ServiceTrak Results(Out of 10 possible satisfaction points)

8.45

8.95

8.63

2013
Competitor 1
Recording a video showing customers how to use an instrument

Making Ongoing Contributions to
Organizations That Support Cancer
Prevention and Research
To achieve its goal of contributing to a healthy society, Sysmex
America regularly donates to organizations that support cancer
prevention and research. In fiscal 2014, the company donateda total of $79,000* to the American Cancer Society, theAmerican Heart Association and the Leukemia & Lymphoma
Society. The company’s employees also actively participatedas volunteers in events held by these societies.
* Including donations received through fund-raising campaigns

Employees and their families who participated in fund-raising events

15

Sysmex Sustainability Report 2015

9.18

2014
Competitor 2

Sysmex Americas

Competitor 3

Industry Avg.

Selected for the Companies That Care Honor
Roll for the Seventh Consecutive Year
Recognized for its corporate citizenship activities and proactive
efforts to make the workplace motivating for employees,
Sysmex America was selected for the Companies That Care
Honor Roll, sponsored by Companies That Care, a U.S. nonprofit
organization. This was the seventh year in a row the company
has been selected for this honor.

Global CSR Activity Highlights

EMEA*

Support for
Non-profit Organization
Building Medical
Infrastructure in Kenya

Helping
to Curb
the Increase inHIV

In fiscal 2010, Sysmex donated hematology analyzers in support ofILFAR, a non-profit organization dedicated to building an HIV/AIDS
treatment infrastructure in Kenya, and Sysmex has continued to provide
support since then. ILFAR provides education about HIV/AIDS andconducts regular free screening in the area. In September 2014, theorganization provided free screening for more than 2,300 residents ofthe village of Pumwani, Kenya. In fiscal 2014, Sysmex made a donation
to ILFAR corresponding to the screening costs for 1,100 people.

Hematology analyzer donated by Sysmex

Providing Training for Distributors
and Employees
Conducting highly precise testing requires an appropriate levelof technological and scientific knowledge. To foster thisexpertise, Sysmex Europe, the regional headquarters for EMEA*,
has established the Sysmex Academy to provide training for
key distributors and employees alike. The company has also
set up training centers in various EMEA regions, providing an
education system that offers instruction supervised by theSysmex Academy.

*Europe, the Middle East and Africa

Infection

Performing treatment

Improving Health through Sports
In fiscal 2014, Sysmex Europe opened the Sysmex Gym, fitted
out with various types of sports equipment. The gym offers
training in various sports, including kick-boxing and pilates.
To foster an interest in sports among numerous employees,
the gym offers entry-level training by professional coaches,and specialists provide massages, creating an environment
where gym-goers can enjoy maintaining their health.

* Europe, the Middle East and Africa

Training at the Sysmex Academy

Sysmex Gym

Sysmex Sustainability Report 201516

Global CSR Activity Highlights

China
Providing Leading-Edge
Scientific Information to
Healthcare Professionals
Since 1998, Sysmex has conducted scientific seminars for healthcare
professionals in China, where economic development and population
growth are leading to rapid growth in demand for healthcare andtesting. On November 1, 2014, we held the 17th Sysmex Scientific
Seminar in China in the city of Kunming. Attended by 780 people fromthroughout China, the seminar disseminated leading-edge informationon laboratory testing.

Seminar underway

Collaborating with a College to
Cultivate Engineers
China, where testing demand is growing at a rapid pace, faces
an urgent need to provide laboratory testing instrument
engineers with the requisite specialized knowledge andtechnological skills. To address this need, Sysmex Shanghai and
the Shanghai Medical Instrumentation College (SMIC) together
operate a training center for engineers. In fiscal 2014, five
SMIC instructors with advanced instruction credentials andthree Sysmex Shanghai engineers with extensive operational
and technological experience participated in this project.

Engineers in training

17

Sysmex Sustainability Report 2015

780

Participants fromthroughout
China

Greeting by President Ietsugu

Wuxi Reagent Factory Named a “Fiscal 2014
Trusted Company” by the Jiangsu Province
Food & Drug Administration
In fiscal 2014, the Sysmex Wuxi Factory was named a “Fiscal
2014 Trusted Company” by the Food & Drug Administrationin Jiangsu Province, where it is located. The authority selected
the Wuxi Factory for this distinction from among all companies
in Jiangsu Province involved in the manufacture of medical
equipment, based on their legal compliance.

Sysmex Wuxi

Global CSR Activity Highlights

Asia PacificExpanding
Our Reagent Factoryin Singapore to
Ensure a Stable Supply
Sysmex is augmenting its reagent production capacity to ensure a stablesupply of reagents to meet a growing demand for testing, particularlyin emerging markets. In fiscal 2014, Sysmex renovated its factory in
Singapore, prioritizing efforts to take the global environment into
account, ensure high manufacturing quality and efficiency, and allow
for future product additions. Production capacity at this factory will
be steadily increased to approximately three times its former level.

Production
Capacity toApproximately

TripleProduction area inside the factory
Building housing the new reagent factory

Contributing to Testing Quality Improvements
in Asian Countries
Sysmex is supporting efforts to put in place healthcare
infrastructure and enhance the quality of healthcare in emerging
markets and developing countries in Asia. For example, we workwith local governments and academic societies to provide
external quality control* in an effort to standardize testing
results. We continued these efforts in fiscal 2014, supporting
external quality control in countries including Mongolia, Thailand
Major Support Activities in Fiscal 2014

Mongolia• Conducted external quality control twice each in the fields of hematology
and clinical chemistry• Concluded an ongoing contract with the Mongolian Ministry of Health toprovide external quality control support• Performed lectures at a seminar attended by institutions participating inexternal quality control

Thailand• Conducted external quality control four times in the hematology field• Performed lectures at a seminar attended by institutions participating inexternal quality control

Philippines • Conducted external quality control three times in the hematology field
Cambodia• Concluded a contract with the Cambodian Ministry of Health to provide
support for external quality control in the hematology field

and the Philippines. Sysmex also provides technological andacademic expertise to local healthcare professionals.
* External quality control: A process for confirming the accuracy of measurement
data by comparing such data from the diagnostic instruments of specific institutions
with those of the reference counter (an instrument that provides measurement data
accepted as standard) and other institutions

Providing Free Screening for a Genetic Blood
Disorder in Indonesia
In Indonesia, a large number of people are affected by thalassemia,
an illness marked by symptoms such as dizziness, but people
with mild cases may not even be aware that they have thedisorder. To address
this situation, in May
2014 Sysmex
Indonesia conducteda free screening eventthat attracted morethan 2,000 people.
Screening event

Sysmex Sustainability Report 201518

Sysmex’s CSR Activities

Based on our corporate philosophy, we have formulated
a mid-term plan and are promoting CSR activities to build
confidence among our stakeholders.
Sysmex CSR Builds Trust and Confidence throughPractice of the Sysmex Way
Sysmex CSR builds trust and confidence among all its
stakeholders through the practice of the Sysmex Way, thecorporate philosophy of the Sysmex Group. The Sysmex Way
indicates the way the most basic corporate activities ought
to be conducted, consisting of three elements necessary forcontinued growth: Mission, Value and Mind. The mission
expresses the expansion of our business from activities
centered on the field of diagnostics—a focus since ourestablishment—to the broader healthcare domain with its
even closer connection to human health. In this manner,
the mission asserts our aim of contributing toward therealization of a society filled with abundance, health and joy.
The Core Behaviors clarify provision of specific value
to customers, employees, business partners, shareholders,society and all our stakeholders. For example, to provide
reassurance to all members of society we carry out ourbusiness in strict compliance with laws and regulations,as well as in adherence to high ethical standards. We also
consider it important to play an active role in resolving
environmental issues and other problems that impact oursociety today.

Promoting CSR Activities Based on the Global
Compact’s 10 Principles and ISO 26000
Sysmex joined the United Nations Global Compact inFebruary 2011 to become more proactive in its CSR initiatives.
We have formulated a mid-term CSR plan and areundertaking CSR activities based on these 10 principles,
as well as ISO 26000, the international standard for sociality.
responsibility.

19

Sysmex Sustainability Report 2015

The UN Global Compact’s 10 Principles

Human Rights

Principle 1: Businesses should support andrespect the protection of internationallyproclaimed human rights; andPrinciple 2: make sure that they are not complicit
in human rights abuses.
Principle 3: Businesses should uphold the freedomof association and the effective recognition of theright to collective bargaining;
Principle 4: the elimination of all forms of forced
and compulsory labour;

LabourPrinciple 5: the effective abolition of childlabour; andPrinciple 6: the elimination of discriminationin respect of employment and occupation.
Principle 7: Businesses should support aprecautionary approach to environmental
challenges;
Environment

Principle 8: undertake initiatives to promote
greater environmental responsibility; andPrinciple 9: encourage the development anddiffusion of environmentally friendly technologies.

Anti-Corruption

Principle 10: Businesses should work against
corruption in all its forms, including extortionand bribery.

Formulation of a New Mid-Term CSR Plan
Responding to Increasingly Diverse andSophisticated Social Requirements and Expectations
In May 2015, Sysmex formulated a new Mid-Term CSR Planin response to increasingly diverse and sophisticated social
requirements and expectations.
Regarding ongoing themes such as risk management
and customer satisfaction, we will reinforce our structuresfrom a global perspective. We also set new targets to increase
employee satisfaction in order to maintain and enhance anattractive and pleasant working place.
For the future, we plan to incorporate the opinions ofstakeholders and define material issues.

Mid-Term CSR Plan (Fiscal 2015–2017)
Category

Mid-Term
CSR Issues

Reinforcement of ourglobal risk management
structure

Measures

Specific Developments (Fiscal 2015)

Deploy a global risk management system•Reinforce the risk management structural baseStrengthen measures to counter significant
Group risks•Step up countermeasures against
information leaks•Promote global fair trade•Roll out global business continuity measures

Ensure thorough compliance and expand
application•Create a complaints management system
related to fair trade•Expand the scope of our compliance policy

Reinforce the global compliance structure•Draft and implement improvement measures
based on evaluations by external specialists

Promote an active role for women•Increase the ratio of female recruits•Conduct career advancement training
for women

Recruit diverse global human resources•Increase hiring ratio of non-Japanese humanresources

Promote global talent management•Implement programs to cultivate global
human resources

Increase employee satisfaction•Promote awareness activities with the aim ofutilizing various programs

Promote environmentally friendly products
and services(Including achieving the Group target values
outlined in Sysmex Eco-Vision 2020)•Reduce greenhouse gas emissions of products
and services

Reduce the environmental impact ofbusiness activities(Including achieving the Group target values
outlined in Sysmex Eco-Vision 2020)•Curtail use of energy, waste and use ofwater resources

Organizational
governanceReinforcement of thecompliance system

Human rights /Labor practices

Cultivation andpromotion of diverse
human resources

Maintenance or
improvement of an
attractive and pleasantworking environment

Environment

Environmental impact
reduction of products,
services and operational
activities

Fair operating
practices

Promotion of
CSR procurement

Continue to promote CSR procurement•Select new business partners based on new
procurement policies and promote awarenessamong existing business partners

Consumer issues

Improvement ofcustomer satisfaction

Create a global customer satisfaction
evaluation system•Conduct a global customer satisfaction survey

Community
involvement anddevelopment

Promotion of corporate
citizenship activities

Conduct corporate citizenship activities basedon the Policy on Corporate Citizenship
Activities and Philanthropy•Continue to conduct corporate citizenshipactivities•Increase the number of employee volunteers bypromoting a social contribution points program

Sysmex Sustainability Report 201520

Corporate Information(As of March 31, 2015)

Corporate Overview
Company name Sysmex Corporation
EstablishedFebruary 20, 1968

Paid-in capital¥10,483.33 million

Representative

Hisashi Ietsugu, Chairman and CEO

Head Office

1-5-1, Wakinohama-Kaigandori, Chuo-ku,
Kobe 651-0073, Japan

Line of business

Development, manufacture, sales, and export/importof laboratory testing instruments, reagents, andrelated software

Operating Income

Net Sales

221,376(¥ million)

44,411(¥ million)

184,538
32,870145,577
124,694 134,743

2010

2011

2012

2013 2014(FY)

Net Income

18,28819,205 21,804

2010

2011

2012

2013 2014(FY)

Number of Employees

26,638(¥ million)

20,573
11,411

12,007

2010

2011

4,932

5,314

5,594

2011

2012

6,211

6,739

14,16520122013 2014

2010

(FY)

2013 2014(FY)

Note: Including contract workers and part-time employees

Information Available
on the Website
Comprehensive Information Provided
on the CSR Site
Sysmex CSR

SearchMessage from the Chairman and CEO
Sysmex’s CSR Activities• CSR Management • Mid-Term CSR Plan
• Results of Dialogue with Stakeholders• Summary of CSR Data • External Evaluation

Corporate GovernanceCompliance
Risk Management
2015 CSR Activity Highlights
Expanding our Lineup of Immunoassay Analyzers
and Reagents That Contribute to the Early
Detection and Treatment of Infectious Diseases,
Cancer and Other Diseases
2 Opening of i-Square, a Core Instrument
Factory Focused on Delivering High-Quality
Products in a Stable Manner
3 Employee Volunteers Conduct Fund-RaisingCampaign to Help Fight Cancer
1

21

Sysmex Sustainability Report 2015

Involvement with Stakeholders• Involvement with Customers•Ensuring Quality and Safety•After-Sales Support/Scientific Activities• Stable Supply•Enhancing Customer Satisfaction and
Third-Party Evaluations•Contributing to Resolution of Healthcare Issues• Involvement with Shareholders• Involvement with Business Partners• Involvement with Employees•Respecting Human Rights and Diversity•Employee Evaluation, Treatment,
and Human Resource Development•Ensuring a Work-Life Balance•Respecting Workers’ Rights•Considering Safety and HealthCorporate Citizenship Activities• Policy on Corporate Citizenship Activities
and Philanthropy• Activities to Promote a Healthy Society• Contributing to Local Communities• Promoting Employees’ Social
Contribution Activities

Net Sales by Destination/Regional Subsidiaries and Affiliates¥40.6

Employees by Region

billionJapan

10 companies¥49.6

billion968

Americas

10 companies¥63.6

29 companies

¥49.8

EMEA*

billionbillion*Europe, the Middle East
and Africa

billion13 companies

1,756
394

China

4 companies

¥17.8

3,085

Asia Pacific536

Environmental Conservation Activities• Environmental Policy• Environmental Management• Environmentally Conscious Products and Services• Environmental Consciousness at Business Offices• Other Environmental Considerations• Green Procurement• Environmental Data

Sysmex Sustainability Report
Guideline Comparative Table

Sysmex Sustainability Report 201522

1-5-1, Wakinohama-Kaigandori, Chuo-ku, Kobe 651-0073, Japan
Tel +81-78-265-0500 Fax +81-78-265-0524